These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 9545811)

  • 1. [Leukemia specific chimeric protein as a target molecule for chemotherapy].
    Naoe T
    Rinsho Ketsueki; 1998 Feb; 39(2):105-6. PubMed ID: 9545811
    [No Abstract]   [Full Text] [Related]  

  • 2. Identification of a complex (11;17;15) translocation in acute promyelocytic leukemia.
    Douet-Guilbert N; Morel F; Le Bris MJ; De Braekeleer M
    Cancer Genet Cytogenet; 2005 Nov; 163(1):93-4. PubMed ID: 16271965
    [No Abstract]   [Full Text] [Related]  

  • 3. Mechanism-based therapy for leukemia: a lesson from ATRA therapy.
    Naoe T
    Nagoya J Med Sci; 2001 Nov; 64(3-4):103-8. PubMed ID: 11820331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A unique case of acute promyelocytic leukemia showing monocytic differentiation after ATRA (all-trans retinoic acid) therapy.
    Naeem M; Harrison K; Barton K; Nand S; Alkan S
    Eur J Haematol; 2006 Feb; 76(2):164-6. PubMed ID: 16405439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute promyelocytic leukemia (AML-M3)--Part 2: Molecular defect, DNA diagnosis, and proposed models of leukemogenesis and differentiation therapy.
    Randolph TR
    Clin Lab Sci; 2000; 13(2):106-16. PubMed ID: 11066449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful treatment of acute promyelocytic leukemia with a t(X;17)(p11.4;q21) and BCOR-RARA fusion gene.
    Ichikawa S; Ichikawa S; Ishikawa I; Takahashi T; Fujiwara T; Harigae H
    Cancer Genet; 2015 Apr; 208(4):162-3. PubMed ID: 25790901
    [No Abstract]   [Full Text] [Related]  

  • 7. Acute promyelocytic leukemia: from treatment to genetics and back.
    Kogan SC; Bishop JM
    Oncogene; 1999 Sep; 18(38):5261-7. PubMed ID: 10498878
    [No Abstract]   [Full Text] [Related]  

  • 8. Cryptic insertion (15;17) in a case of acute promyelocytic leukemia detected by fluorescence in situ hybridization.
    Gutiérrez NC; García JL; Chillón C; Muntión S; González M; Hernández JM
    Haematologica; 1999 Jan; 84(1):88-90. PubMed ID: 10091399
    [No Abstract]   [Full Text] [Related]  

  • 9. [Arsenic and retinoic acid, towards targeted treatments of acute promyelocytic leukemia?].
    de Thé H
    Bull Acad Natl Med; 1998; 182(1):63-71. PubMed ID: 9622932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significance of persistent Auer rods and cytogenetic abnormality after first cycle of therapy for acute promyelocytic leukaemia.
    Dalal BI; Bruyere H; Barnett MJ
    Br J Haematol; 2007 Jun; 137(5):385. PubMed ID: 17374141
    [No Abstract]   [Full Text] [Related]  

  • 11. Therapy-related myeloproliferative neoplasm with ETV6-PDGFRB rearrangement following treatment of acute promyelocytic leukemia.
    Malfuson JV; Konopacki J; Fagot T; Desangles F; Bories D; Souleau B; de Revel T
    Ann Hematol; 2011 Dec; 90(12):1477-9. PubMed ID: 21350831
    [No Abstract]   [Full Text] [Related]  

  • 12. The maturation of differentiation therapy.
    Cheson BD
    N Engl J Med; 1992 Aug; 327(6):422-4. PubMed ID: 1625719
    [No Abstract]   [Full Text] [Related]  

  • 13. Diagnosis, front line treatment and molecular monitoring of acute promyelocytic leukaemia.
    Lo Coco F; Diverio D; Avvisati G; Mandelli F
    Haematologica; 1999 Jun; 84 Suppl EHA-4():72-4. PubMed ID: 10907474
    [No Abstract]   [Full Text] [Related]  

  • 14. Molecular targets and the treatment of myeloid leukemia.
    Ikeda A; Shankar DB; Watanabe M; Tamanoi F; Moore TB; Sakamoto KM
    Mol Genet Metab; 2006 Jul; 88(3):216-24. PubMed ID: 16678459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pituitary relapse of acute promyelocytic leukemia after ATRA.
    Lugassy G; Halperin Y
    Int J Hematol; 1998 Jul; 68(1):101-2. PubMed ID: 9713174
    [No Abstract]   [Full Text] [Related]  

  • 16. [Current therapeutic concept of acute promyelocytic leukemia].
    Lengfelder E; Hehlmann R; Büchner T
    Dtsch Med Wochenschr; 2001 Sep; 126(39):1073-9. PubMed ID: 11602915
    [No Abstract]   [Full Text] [Related]  

  • 17. [Acute promyelocytic leukemia, histone deacetylase, and response to retinoids].
    Jeanteur P
    Bull Cancer; 1998 Apr; 85(4):301-3. PubMed ID: 9752292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute promyelocytic leukemia: new issues on pathogenesis and treatment response.
    Vitoux D; Nasr R; de The H
    Int J Biochem Cell Biol; 2007; 39(6):1063-70. PubMed ID: 17468032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapy-related acute myeloid leukemia after successful therapy for acute promyelocytic leukemia with t(15;17): A case report and literature review.
    Bao L; Lu X; Lai Y; Zhang X; Zhu H; Liu Y; Qin Y; Huang XJ
    Leuk Res; 2009 Jul; 33(7):e64-8. PubMed ID: 19297021
    [No Abstract]   [Full Text] [Related]  

  • 20. Acute Promyelocytic Leukemia.
    Winkler C
    N Engl J Med; 2024 May; 390(17):e42. PubMed ID: 38683728
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.